Although phenotypic characterisation of colon CSCs is still controversial, CD133 is presently considered a useful marker to identify CSC in colorectal cancers and its detection has been used to evaluate the prognostic significance of CSC in colon cancer patients[1-3]. This evidence concerns the gene PROM1 and colorectal cancer.